NASDAQ · INGN
Inogen, Inc
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for INGN: Nov 05, 2026
Inogen, Inc Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $-0.2.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · MarketBeat- Zacks · Aug 21, 11:46 AM EDTHere's Why You Should Retain Inogen Stock in Your Portfolio for NowINGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.
- Zacks · Aug 19, 10:08 AM EDTIs IDXX Worth Buying as Growth Strength Meets a Premium Valuation?IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valuation that supports a hold-or-wait stance.
- The Motley Fool · Aug 14, 11:03 AM EDTInogen (INGN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 11, 12:23 PM EDTInogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure PersistsINGN cuts its 2026 revenue outlook as U.S. channel pressure weighs, while international growth, new products and cost control offer support.
- Zacks · Aug 11, 12:22 PM EDTShould Investors Buy Inogen as Low Valuation Meets Execution Risk?Inogen's steep sales-multiple discount, improving margins and firm international demand clash with U.S. sales and rental weakness.
- Zacks · Aug 10, 12:54 PM EDTInogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View CutINGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook.
- MarketBeat · Aug 6, 11:03 PM EDTInogen Q2 Earnings Call HighlightsInogen (NASDAQ:INGN) reported second-quarter 2026 revenue of $95.1 million, up 3% from a year earlier, as international growth, portable oxygen concentrator demand and contributions from newer products offset continued pressure in its U.S. direct-to-consumer business. The compan
- Zacks · Aug 6, 7:10 PM EDTInogen (INGN) Reports Q2 Loss, Tops Revenue EstimatesInogen (INGN) delivered earnings and revenue surprises of +17.65% and +0.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 8, 10:41 AM EDTINGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin ImprovesInogen posts higher Q1 revenues and improved gross margin as international portable oxygen demand offsets weaker U.S. sales.
- MarketBeat · May 8, 12:06 AM EDTInogen Q1 Earnings Call HighlightsInogen (NASDAQ:INGN) reported first-quarter 2026 revenue of $85.1 million, up 3.4% year over year and “ahead of our expectations,” President and CEO Kevin Smith said on the company’s earnings call. Management pointed to continued strength internationally, partially offset by ongo
- The Motley Fool · May 7, 8:08 PM EDTInogen (INGN) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 7, 7:05 PM EDTInogen (INGN) Reports Q1 Loss, Beats Revenue EstimatesInogen (INGN) delivered earnings and revenue surprises of -25.00% and +3.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Inogen, Inc from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.